<DOC>
	<DOCNO>NCT01146925</DOCNO>
	<brief_summary>The primary objective trial assess impact CRMD-001 marker contrast-induced acute kidney injury ( AKI ) high-risk patient chronic kidney disease ( CKD ) undergo coronary angiography PCI .</brief_summary>
	<brief_title>Deferiprone Prevention Contrast-Induced Acute Kidney Injury</brief_title>
	<detailed_description>This trial evaluate whether treatment CRMD-001 ( unique formulation iron chelator , Deferiprone ) reduce incidence AKI subject CKD additional risk factor . Adult subject moderate severe CKD undergo coronary angiography PCI randomize either placebo CRMD-001 follow 90 day . Subjects receive 8 day randomize therapy start 1-3 hour prior angiography . The primary endpoint trial difference mean pair change panel sensitive renal biomarkers group . Differences renal cardiovascular clinical event also evaluate .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Deferiprone</mesh_term>
	<criteria>1 . Age 18 old 2. eGFR &lt; 60 ml/min/1.73 m2 3 . Presence least one additional risk factor : Diabetes Mellitus Age ≥ 75 year Left Ventricular Ejection Fraction ≤ 40 % 1 . EndStage Renal Disease 2 . Recent change serum creatinine 3 . Primary PCI STEMI 4 . Currently receive mechanical ventilation 5 . Severe heart failure cardiogenic shock 6 . Requirement inotropic support ( prior 30 day ) 7 . Sustained hypertension &gt; = 200/110 8 . Subject expect live 90 day 9 . Anticipated use ioxaglate iohexol 10 . Currently receive fenoldopam , dopamine , theophylline , aminophylline , mannitol , Nacetyl cysteine Ascorbic acid 11 . Absolute neutrophil count &lt; 1500 12 . Hemoglobin &lt; 8 gm/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Acute Kidney Injury</keyword>
	<keyword>Contrast-Induced Nephropathy</keyword>
	<keyword>Labile Iron</keyword>
	<keyword>Iron Chelation</keyword>
	<keyword>Deferiprone</keyword>
</DOC>